Infectious complications after autologous stem cell transplantation
| Case | Infection | Time* | Case | Infection | Time* |
|---|---|---|---|---|---|
| *Time point after autologous stem cell transplantation. | |||||
| †Death. | |||||
| CMV, cytomegalovirus; CNS, coagulase negative staphylococcus; EBV, Epstein-Barr virus; HSV, herpes simplex virus; MAS, macrophage activation syndrome; VZV, varicella-zoster virus. | |||||
| 1 | VZV, skin | <3 m | 17 | Streptococcus mitis, blood | <3 m |
| 2 | Mycobacterium szulgai, eye | 6 m | CMV reactivation | <3 m | |
| 3 | Xanthomonas maltophilia, stool | <3 m | VZV, skin | 12 m | |
| HSV, hepatitis | 24 m | 18 | HSV type 1, throat | <3 m | |
| 4 | EBV, disseminated† | 12 m | 19 | Streptococcus mitis, blood | <3 m |
| Streptococcus viridans, blood | <3 m | Generalised VZV | <3 m | ||
| 5 | VZV, skin | <3 m | Primary CMV | <3 m | |
| 6 | VZV, skin | 6 m | Candida oesophagitis | <3 m | |
| Hepatitis A | 18 m | 20 | None | ||
| 7 | Streptococcus, blood | <3 m | 21 | VZV, skin† | 12 m |
| VZV, skin | 18 m | 22 | None | ||
| 8 | CMV reactivation | 4 m | 23 | Cryptosporidium, stool | <3 m |
| EBV (†, MAS) | 4 m | 24 | None | ||
| Candida oesophagitis | <3 m | 25 | Candidal oesophagitis | <3 m | |
| 9 | CNS, blood | <3 m | 26 | Toxoplasmosis, generalised (†, MAS) | <3 m |
| VZV, skin | 9 m | 27 | None | ||
| 10 | None | 28 | Parainfluenza, blood | <3 m | |
| 11 | H influenzae, blood | <3 m | CMV reactivation, blood | <3 m | |
| CNS, blood | <3 m | 29 | Legionella pneumonia | <3 m | |
| VZV, skin | 9 m | CMV reactivation | <3 m | ||
| 12 | None | 30 | CNS, blood | <3 m | |
| 13 | VZV skin | <3 m | CMV reactivation, blood | <3 m | |
| CMV reactivation | <3 m | HSV, stomatitis | <3 m | ||
| 14 | None | Parainfluenza, blood | <3 m | ||
| 15 | CNS, blood | <3 m | 31 | CNS, blood | <3 m |
| Adenovirus type 3, faeces† | <3 m | 32 | None | ||
| 16 | HSV type 1, throat | 12 m | 33 | None | |
| Influenza A, nose | <3 m | 34 | ↑ EBV genome copies | <3 m | |
| VZV, skin | 4 m | ||||